Adaptive Designs, Real World
Despite potential advantages, pharma is taking a cautious approach to adaptive designs, resulting in a slow but sure restyling of the research enterprise.
By Deborah Borfitz
Reynders identifies the big challenges for informatics.
Predicting Patient Response
Vertex CEO champions modeling in drug development.
Avey proposes a new genomics paradigm.
The Genome Out of the Bottle
Industry pioneers discuss the pros and cons.
Expo Conference Tracks
From predictive modeling to personalized medicine.
2008 Best of Show Competition
Over 30 products competed for Best of Show honors.
Now and Future Sequencing Stories
Companies unveil next-generation sequencers and data.
GNS: From SNPs to Outcomes
Colin Hill is gunning to turn raw data into key SNP discoveries.
A Virtual Pharma Organization
With private funding and Duke’s help, Roses focuses on discovery and development.
Inside Intel’s Interest in Sequencing
Intel strives to “standardize the base.”
ACORN offers equal opportunity research.
Bio-Imaging Buys Phoenix
Expects EDC synergies with PDS.
Building Buzz in Singapore
The hub is selling location, talent, and the Biopolis of Asia.
Scotland’s Bonny Approach to Life Sciences
Collaboration is the life sciences’ strategy of the future.
Oxford Open for Business
England benefits from critical mass of clever individuals.
Biotech Investments Across the Union
States make investments in the life sciences.
IN EVERY ISSUE
The Buzz at Bio-IT World
FIRST BASE | Insiders present top ten industry highlights.
By Kevin Davies
Best Practices: Gloom and Doom Antidote
THE RUSSELL TRANSCRIPT | 2008 Best Practices winners set the bar for innovation.
By John Russell